Literature DB >> 19802608

Modeling multiple sclerosis in laboratory animals.

Bettina Schreiner1, Frank L Heppner, Burkhard Becher.   

Abstract

Inflammatory demyelinating disease of the central nervous system is one of the most frequent causes of neurological disability in young adults. While in situ analysis and in vitro models do shed some light onto the processes of tissue damage and cellular interactions, the development of neuroinflammation and demyelination is a far too complex process to be adequately modeled by simple test tube systems. Thus, animal models using primarily genetically modified mice have been proven to be of paramount importance. In this chapter, we discuss recent advances in modeling brain diseases focusing on murine models and report on new tools to study the pathogenesis of complex diseases such as multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19802608     DOI: 10.1007/s00281-009-0181-4

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  228 in total

Review 1.  Are astrocytes central players in the pathophysiology of multiple sclerosis?

Authors:  Jacques De Keyser; Esther Zeinstra; Elliot Frohman
Journal:  Arch Neurol       Date:  2003-01

2.  Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

Authors:  Ingunn M Stromnes; Lauren M Cerretti; Denny Liggitt; Robert A Harris; Joan M Goverman
Journal:  Nat Med       Date:  2008-02-17       Impact factor: 53.440

3.  Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.

Authors:  C L Vanderlugt; K L Neville; K M Nikcevich; T N Eagar; J A Bluestone; S D Miller
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

4.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

5.  Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.

Authors:  Petra G Hirrlinger; Anja Scheller; Christian Braun; Johannes Hirrlinger; Frank Kirchhoff
Journal:  Glia       Date:  2006-07       Impact factor: 7.452

6.  Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.

Authors:  Gurumoorthy Krishnamoorthy; Hans Lassmann; Hartmut Wekerle; Andreas Holz
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

7.  Distinct roles of protein kinase R and toll-like receptor 3 in the activation of astrocytes by viral stimuli.

Authors:  Pamela A Carpentier; Bryan R Williams; Stephen D Miller
Journal:  Glia       Date:  2007-02       Impact factor: 7.452

8.  Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes.

Authors:  Julie Cabarrocas; Jan Bauer; Eliane Piaggio; Roland Liblau; Hans Lassmann
Journal:  Eur J Immunol       Date:  2003-05       Impact factor: 5.532

9.  Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination.

Authors:  Jeffrey L Mason; Shouhong Xuan; Ioannis Dragatsis; Argiris Efstratiadis; James E Goldman
Journal:  J Neurosci       Date:  2003-08-20       Impact factor: 6.167

10.  Studies on autoimmune encephalomyelitis in the guinea pig. II. An in vitro investigation on the nature, properties, and specificity of the serum-demyelinating factor.

Authors:  R Lebar; J M Boutry; C Vincent; R Robineaux; G A Voisin
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

View more
  23 in total

1.  Evaluation of a transgenic mouse model of multiple sclerosis with noninvasive methods.

Authors:  Mabel Enriquez-Algeciras; Di Ding; Tsung-Han Chou; Jianhua Wang; Kyle R Padgett; Vittorio Porciatti; Sanjoy K Bhattacharya
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-14       Impact factor: 4.799

2.  Sall1 is a transcriptional regulator defining microglia identity and function.

Authors:  Anne Buttgereit; Iva Lelios; Xueyang Yu; Melissa Vrohlings; Natalie R Krakoski; Emmanuel L Gautier; Ryuichi Nishinakamura; Burkhard Becher; Melanie Greter
Journal:  Nat Immunol       Date:  2016-10-24       Impact factor: 25.606

Review 3.  End-point effector stress mediators in neuroimmune interactions: their role in immune system homeostasis and autoimmune pathology.

Authors:  Mirjana Dimitrijevic; Stanislava Stanojevic; Natasa Kustrimovic; Gordana Leposavic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

Review 4.  The development of myelin repair agents for treatment of multiple sclerosis: progress and challenges.

Authors:  Robert P Murphy; Keith J Murphy; Mark Pickering
Journal:  Bioengineered       Date:  2012-11-12       Impact factor: 3.269

5.  Differential targeting of IL-2 and T cell receptor signaling pathways selectively expands regulatory T cells while inhibiting conventional T cells.

Authors:  Atsushi Satake; Amanda M Schmidt; Angela Archambault; Theresa M Leichner; Gregory F Wu; Taku Kambayashi
Journal:  J Autoimmun       Date:  2013-07-05       Impact factor: 7.094

Review 6.  Spontaneous ocular and neurologic deficits in transgenic mouse models of multiple sclerosis and noninvasive investigative modalities: a review.

Authors:  Archana A Gupta; Di Ding; Richard K Lee; Robert B Levy; Sanjoy K Bhattacharya
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-13       Impact factor: 4.799

7.  Erythropoietin enhances endogenous haem oxygenase-1 and represses immune responses to ameliorate experimental autoimmune encephalomyelitis.

Authors:  Shyi-Jou Chen; Yen-Ling Wang; Wen-Tsung Lo; Chia-Cho Wu; Chia-Wen Hsieh; Ching-Feng Huang; Yu-Hsin Lan; Chih-Chien Wang; Deh-Ming Chang; Huey-Kang Sytwu
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

8.  Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases.

Authors:  Gregory F Wu; Chelsea R Parker Harp; Kenneth S Shindler
Journal:  Curr Immunol Rev       Date:  2015

9.  3,3'-diindolylmethane ameliorates experimental autoimmune encephalomyelitis by promoting cell cycle arrest and apoptosis in activated T cells through microRNA signaling pathways.

Authors:  Michael Rouse; Roshni Rao; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2014-06-04       Impact factor: 4.030

10.  Neuropathic pain in animal models of nervous system autoimmune diseases.

Authors:  David H Tian; Chamini J Perera; Gila Moalem-Taylor
Journal:  Mediators Inflamm       Date:  2013-05-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.